Упрощенная HTML-версия
132
167. Circulating inflammatory mediators during start of fever in
differential diagnosis of gram-negative and gram-positive infections in
leukopenic rats / E.
et al.] //
– 2005. – Vol.
12, № 9. – P. 1085-1093.
168. Cochrane Injuries Group: Human albumin administration in
critically ill patient (systematic review of randomized, controlled trials / BMJ.-
1998. – N 237. – P. 319-334.
169.
Connolly A. Urinary tract infections in pregnancy /A. Connolly,
J.M.Jr. Thorp // Urol. Clin. North. Am. – 1999. – V.26, N4. – P.779-787.
170.
Dandona P., Nix P. et al. Procalcitonin increase after endotoxine
injection in normal subjects / P. Dandona [et al.]
// J. Clin. Endocrinol. Metab. -
1994. – Vol. 79, N6. – P. 1605-1608.
171. Differential regulation of cytokine and chemokine production in
lipopolysaccharide-induced tolerance and priming / O.M.
et al.] //
– 2004. – Vol. 26, № 5. – P. 202-208.
172.
Foxman B. Epidemiology of urinary tract infection: incidence
morbidity and economic costs / B. Foxman // Am. J Med. – 2002. – Vol. 113, N
1. – P. 58-113.
173.
Goldfeld A.E. TNF – alpha and genetic susceptibility to parasitic
disease / A.E. Goldfeld, E.Y. Tsai // Exp. Parasitol. – 1996. – Vol. 84, N 2. – P.
300 – 303.
174.
Hooton T.M. Practice guidelines for urinary tract infection in the
era of managed care / T.M. Hooton // Int. J Antimicrob. Agents. – 1999. – Vol.
11. – P. 241.
175.
Immunoparalysis in sepsis – from phenomenon to treatment
strategies / W.D. Docke [et al.] // Transplantation medizin. – 1997. – V. 9. – P.
55-65.